标题
Transcription Inhibition as a Therapeutic Target for Cancer
作者
关键词
-
出版物
Cancers
Volume 3, Issue 4, Pages 4170-4190
出版商
MDPI AG
发表日期
2011-11-24
DOI
10.3390/cancers3044170
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Activity of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed, genetically high risk chronic lymphocytic leukemia (CLL)
- (2017) T. S. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol
- (2011) K A Blum et al. LEUKEMIA
- The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine
- (2011) E Walsby et al. LEUKEMIA
- Cyclin-dependent kinase inhibitor, P276-00 induces apoptosis in multiple myeloma cells by inhibition of Cdk9-T1 and RNA polymerase II-dependent transcription
- (2011) Sonal M. Manohar et al. LEUKEMIA RESEARCH
- The Cyclin-Dependent Kinase Inhibitor SCH 727965 (Dinacliclib) Induces the Apoptosis of Osteosarcoma Cells
- (2011) W. Fu et al. MOLECULAR CANCER THERAPEUTICS
- Requirement of TFIIH kinase subunit Mat1 for RNA Pol II C-terminal domain Ser5 phosphorylation, transcription and mRNA turnover
- (2011) Katja Helenius et al. NUCLEIC ACIDS RESEARCH
- 8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma
- (2010) J. B. Dennison et al. BLOOD
- S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition
- (2010) Annette Hayden et al. BREAST CANCER RESEARCH AND TREATMENT
- Responses in Mantle Cell Lymphoma Cells to SNS-032 Depend on the Biological Context of Each Cell Line
- (2010) R. Chen et al. CANCER RESEARCH
- Novel anticancer compounds induce apoptosis in melanoma cells
- (2010) Uppoor G. Bhat et al. CELL CYCLE
- Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma
- (2010) Wei-Gang Tong et al. JOURNAL OF CLINICAL ONCOLOGY
- Nucleoside analog ARC targets Mcl-1 to induce apoptosis in leukemia cells
- (2010) U G Bhat et al. LEUKEMIA
- 8-Amino-Adenosine Inhibits Multiple Mechanisms of Transcription
- (2010) J. A. Frey et al. MOLECULAR CANCER THERAPEUTICS
- Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
- (2010) David Parry et al. MOLECULAR CANCER THERAPEUTICS
- AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition
- (2010) L Santo et al. ONCOGENE
- Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases
- (2010) Kamil Paruch et al. ACS Medicinal Chemistry Letters
- Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia
- (2009) Rong Chen et al. BLOOD
- A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels
- (2009) Christine M. Stellrecht et al. BREAST CANCER RESEARCH AND TREATMENT
- Preclinical activity of 8-chloroadenosine with mantle cell lymphoma: roles of energy depletion and inhibition of DNA and RNA synthesis
- (2009) Jennifer B. Dennison et al. BRITISH JOURNAL OF HAEMATOLOGY
- SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples
- (2009) Andrew Conroy et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer
- (2009) W.-S. Hsieh et al. CLINICAL CANCER RESEARCH
- The basal initiation machinery: beyond the general transcription factors
- (2009) Timothy W. Sikorski et al. CURRENT OPINION IN CELL BIOLOGY
- The transcription elongation factors NELF, DSIF and P-TEFb control constitutive transcription in a gene-specific manner
- (2009) Toshitsugu Fujita et al. FEBS LETTERS
- RNA Polymerase II C-terminal Heptarepeat Domain Ser-7 Phosphorylation Is Established in a Mediator-dependent Fashion
- (2009) Stefan Boeing et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Flavopiridol, Fludarabine, and Rituximab in Mantle Cell Lymphoma and Indolent B-Cell Lymphoproliferative Disorders
- (2009) Thomas S. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- TFIIH-Associated Cdk7 Kinase Functions in Phosphorylation of C-Terminal Domain Ser7 Residues, Promoter-Proximal Pausing, and Termination by RNA Polymerase II
- (2009) K. Glover-Cutter et al. MOLECULAR AND CELLULAR BIOLOGY
- Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines
- (2009) M. S. Squires et al. MOLECULAR CANCER THERAPEUTICS
- Progression through the RNA Polymerase II CTD Cycle
- (2009) Stephen Buratowski MOLECULAR CELL
- Shifting Players and Paradigms in Cell-Specific Transcription
- (2009) Joseph A. D'Alessio et al. MOLECULAR CELL
- Phosphorylation of the RNA polymerase II C-terminal domain by TFIIH kinase is not essential for transcription of Saccharomyces cerevisiae genome
- (2009) S. W. Hong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia
- (2008) M. A. Phelps et al. BLOOD
- RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells
- (2008) Lisa S. Chen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Targeting MET transcription as a therapeutic strategy in multiple myeloma
- (2008) Cornel J. Phillip et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- TFIID component TAF7 functionally interacts with both TFIIH and P-TEFb
- (2008) A. Gegonne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology
- (2008) S WANG et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started